- Home
- INBS vs AIMD Comparison
INBS vs AIMD Comparison
Compare INBS & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBS
- AIMD
- Stock Information
- Founded
- INBS 2016
- AIMD 1984
- Country
- INBS United States
- AIMD United States
- Employees
- INBS N/A
- AIMD N/A
- Industry
- INBS Medical Specialities
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- INBS Health Care
- AIMD Health Care
- Exchange
- INBS Nasdaq
- AIMD Nasdaq
- Market Cap
- INBS 8.7M
- AIMD 8.2M
- IPO Year
- INBS N/A
- AIMD N/A
- Fundamental
- Price
- INBS $1.24
- AIMD $0.54
- Analyst Decision
- INBS
- AIMD
- Analyst Count
- INBS 0
- AIMD 0
- Target Price
- INBS N/A
- AIMD N/A
- AVG Volume (30 Days)
- INBS 113.6K
- AIMD 168.9K
- Earning Date
- INBS 05-13-2025
- AIMD 05-12-2025
- Dividend Yield
- INBS N/A
- AIMD N/A
- EPS Growth
- INBS N/A
- AIMD N/A
- EPS
- INBS N/A
- AIMD N/A
- Revenue
- INBS $2,936,472.00
- AIMD $20,729.00
- Revenue This Year
- INBS $280.88
- AIMD N/A
- Revenue Next Year
- INBS $126.26
- AIMD N/A
- P/E Ratio
- INBS N/A
- AIMD N/A
- Revenue Growth
- INBS 3.87
- AIMD N/A
- 52 Week Low
- INBS $1.00
- AIMD $0.40
- 52 Week High
- INBS $3.04
- AIMD $1.46
- Technical
- Relative Strength Index (RSI)
- INBS 43.94
- AIMD 50.95
- Support Level
- INBS $1.16
- AIMD $0.51
- Resistance Level
- INBS $1.43
- AIMD $0.57
- Average True Range (ATR)
- INBS 0.10
- AIMD 0.04
- MACD
- INBS 0.02
- AIMD -0.00
- Stochastic Oscillator
- INBS 42.42
- AIMD 36.71
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.